Donepezil and Memantine Dosing in Renal Impairment
Donepezil requires no dose adjustment regardless of renal function severity, while memantine must be reduced to 5 mg twice daily in patients with severe renal impairment (creatinine clearance 5-29 mL/min).
Donepezil Dosing
No dose adjustment is necessary for donepezil in any degree of renal impairment, including patients on dialysis. Pharmacokinetic studies demonstrate that donepezil elimination is not significantly altered by renal dysfunction 1. In a study of patients with moderately to severely impaired renal function (creatinine clearance <30 mL/min/1.73 m²), there were no statistical differences in Cmax, AUC, or half-life compared to healthy controls 1.
- Standard dosing (5-10 mg daily) can be maintained across all levels of renal function
- This includes patients on chronic hemodialysis, where donepezil has been safely used at 2.5-5 mg daily without toxicity 2
- The drug is primarily metabolized hepatically rather than renally excreted, explaining the lack of accumulation
Memantine Dosing
For severe renal impairment (creatinine clearance 5-29 mL/min), reduce memantine to a target dose of 5 mg twice daily 3. This represents a 50% dose reduction from the standard 10 mg twice daily maintenance dose.
Dosing Algorithm by Renal Function:
- Normal renal function or mild impairment (CrCl >50 mL/min): Standard titration to 10 mg twice daily (20 mg/day total)
- Moderate renal impairment (CrCl 30-49 mL/min): Standard titration to 10 mg twice daily (20 mg/day total) 4
- Severe renal impairment (CrCl 5-29 mL/min): Reduce target dose to 5 mg twice daily (10 mg/day total) 3, 4
Rationale for Memantine Adjustment:
Pharmacokinetic studies show that memantine exposure (AUC) increases by 60% in moderate renal impairment and 115% in severe renal impairment compared to normal function 4. The drug is primarily eliminated unchanged through renal excretion, with urinary recovery decreasing from 34% to 16% as renal function declines 5. Simulations predict that the 5 mg twice daily regimen in severe renal impairment achieves steady-state concentrations (84 ng/mL) comparable to those in healthy subjects on standard dosing 4.
Practical Considerations
Monitor for conditions that alkalinize urine (e.g., urinary tract infections, renal tubular acidosis, strict vegetarian diet) in patients taking memantine, as elevated urine pH decreases memantine elimination and can lead to drug accumulation even with appropriate dose adjustment 3.
For patients with fluctuating renal function or acute kidney injury superimposed on chronic kidney disease, reassess creatinine clearance before each dose escalation of memantine. The consensus recommendation from geriatric pharmacists supports these adjustments 6.
Common pitfall: Using serum creatinine alone without calculating creatinine clearance, particularly in elderly patients with low muscle mass where serum creatinine may appear normal despite significantly reduced GFR. Always calculate creatinine clearance using the Cockcroft-Gault equation or estimate GFR when dosing these medications in older adults.